Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suvorexant for Insomnia in Co-occurring AUD and PTSD
NCT06679062Phase 2Recruiting
- Sponsor
- Pharmacotherapies for Alcohol and Substance Use Disorders Alliance
- Start
- Jul 2025
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of suvorexant in Insomnia, alcohol use disorder (AUD), post-traumatic stress disorder (PTSD), sponsored by Pharmacotherapies for Alcohol and Substance Use Disorders Alliance. Started Jul 2025; status: recruiting.
02
Drugs
suvorexant
03
Conditions
Insomniaalcohol use disorder (AUD)post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT06679062.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06679062.